Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Franchi

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
JACC. Cardiovascular Interventions|December 23, 2017
De-Escalation of Platelet P2Y<sub>12</sub> Receptor Inhibiting Therapy After Percutaneous Coronary Intervention: Does One Size Fit All?Francesco Franchi, Fabiana Rollini
JACC. Cardiovascular Interventions|April 16, 2025
Cangrelor in Patients With Cardiogenic Shock or Cardiac ArrestFabiana Rollini, Francesco Franchi
JACC. Cardiovascular Interventions|September 1, 2024
Genotype-Guided De-Escalation of DAPT: Switching to Real-World PracticeLarisa H Cavallari, Francesco Franchi
JACC. Cardiovascular Interventions|March 10, 2023
Genotype-Guided Selection of Antiplatelet Therapy: The Evidence Moves EastLarisa H Cavallari, Francesco Franchi
JACC. Cardiovascular Interventions|January 19, 2016
Defining a Role for Prasugrel in Patients With Stable Coronary Artery Disease Undergoing Ad Hoc Percutaneous Coronary InterventionDominick J Angiolillo, Francesco Franchi
Nature Reviews. Cardiology|October 8, 2014
Novel antiplatelet agents in acute coronary syndromeFrancesco Franchi, Dominick J Angiolillo
Giornale Italiano Di Cardiologia (2006)|May 22, 2015
[Non-cardiac surgery in patients with previous percutaneous coronary intervention according to the 2014 European guidelines]Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Current Opinion in Cardiology|August 22, 2014
Perspectives on the management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgeryFrancesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Thrombosis and Haemostasis|March 24, 2017
Oral trans-mucosal administration of ticagrelor: is this really the future?Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Circulation. Cardiovascular Interventions|June 10, 2015
Defining the link between chronic kidney disease, high platelet reactivity, and clinical outcomes in clopidogrel-treated patients undergoing percutaneous coronary interventionFrancesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
JACC. Cardiovascular Interventions|December 23, 2017
De-Escalation of Platelet P2Y<sub>12</sub> Receptor Inhibiting Therapy After Percutaneous Coronary Intervention: Does One Size Fit All?Francesco Franchi, Fabiana Rollini
JACC. Cardiovascular Interventions|April 16, 2025
Cangrelor in Patients With Cardiogenic Shock or Cardiac ArrestFabiana Rollini, Francesco Franchi
JACC. Cardiovascular Interventions|September 1, 2024
Genotype-Guided De-Escalation of DAPT: Switching to Real-World PracticeLarisa H Cavallari, Francesco Franchi
JACC. Cardiovascular Interventions|March 10, 2023
Genotype-Guided Selection of Antiplatelet Therapy: The Evidence Moves EastLarisa H Cavallari, Francesco Franchi
JACC. Cardiovascular Interventions|January 19, 2016
Defining a Role for Prasugrel in Patients With Stable Coronary Artery Disease Undergoing Ad Hoc Percutaneous Coronary InterventionDominick J Angiolillo, Francesco Franchi
Nature Reviews. Cardiology|October 8, 2014
Novel antiplatelet agents in acute coronary syndromeFrancesco Franchi, Dominick J Angiolillo
Giornale Italiano Di Cardiologia (2006)|May 22, 2015
[Non-cardiac surgery in patients with previous percutaneous coronary intervention according to the 2014 European guidelines]Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Current Opinion in Cardiology|August 22, 2014
Perspectives on the management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgeryFrancesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Thrombosis and Haemostasis|March 24, 2017
Oral trans-mucosal administration of ticagrelor: is this really the future?Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Circulation. Cardiovascular Interventions|June 10, 2015
Defining the link between chronic kidney disease, high platelet reactivity, and clinical outcomes in clopidogrel-treated patients undergoing percutaneous coronary interventionFrancesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Pageof 15